- Withdrawal of Registration Statement (RW)
May 01 2009 - 4:17PM
Edgar (US Regulatory)
Arno
Therapeutics, Inc.
4
Campus Drive, 2
nd
Floor
Parsippany,
NJ 07054
(862)
703-7170
May 1,
2009
VIA
EDGAR
U.S.
Securities and Exchange Commission
100 F
Street, N.E.
Washington,
D.C. 20549
Attention: Mr.
Jeffrey Riedler
|
|
|
|
Re:
|
Arno
Therapeutics, Inc. (the “Company”)
|
|
|
Request
for Withdrawal of Post-Effective Amendment No. 1 to Form
S-1
|
|
|
File No.
333-152660
|
Dear Mr.
Riedler:
On behalf of the Company, the
undersigned respectfully requests withdrawal of the above-referenced
Post-Effective Amendment No. 1 to Form S-1 that was filed with the Securities
and Exchange Commission on April 14, 2009 (the “Post-Effective
Amendment”).
In accordance with Rule 477
promulgated pursuant to the Securities Act of 1933, as amended, the undersigned
confirms that no securities of the Company were sold pursuant to the
Post-Effective Amendment. Effectiveness of the Post-Effective Amendment has not
been granted. The grounds on which the Company makes this application are that
there is no longer any intention to offer or sell securities under the
Post-Effective Amendment.
|
|
|
|
|
|
|
Sincerely,
|
|
|
|
|
|
Arno Therapeutics,
Inc.
|
|
|
|
|
|
|
By:
|
/s/
Brian
Lenz
|
|
|
|
Brian
Lenz
|
|
|
|
Chief
Financial Officer
|
|
|
|
|
|
Arno Therapeutics (CE) (USOTC:ARNI)
Historical Stock Chart
From May 2024 to Jun 2024
Arno Therapeutics (CE) (USOTC:ARNI)
Historical Stock Chart
From Jun 2023 to Jun 2024